Klotho Neurosciences Inc Com
Research Klotho Neurosciences Inc Com (KLTO) on Bullrun: market cap USD 37.72M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKLTO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 37.72M
- Financial periodQ3 2025
- RevenueUSD 0
- Net income-USD 2.90M
- Free cash flow-USD 1.09M
Valuation Snapshot
latest market cap is USD 37.72M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | USD 0 | -USD 6.15M | -USD 3.07M | n/a | -0.32 | USD 63.74K | USD 271.75K | USD 1.19M |
| FY2023 | USD 0 | -USD 707.46K | -USD 460.80K | n/a | 0 | USD 2.81K | USD 1.47M | USD 571.72K |
| FY2022 | USD 0 | -USD 598.59K | -USD 724.98K | n/a | 0 | USD 75.87K | USD 1.35M | USD 1.18M |
| FY2021 | USD 0 | -USD 1.11M | -USD 284.02K | n/a | 0 | USD 300.85K | n/a | USD 1.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-03-11 | USD 37.72M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 21.04M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 13.27M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | n/a | 107.0 | n/a | n/a |
| 2022 | 2022-12-30 | n/a | 335.3 | n/a | n/a |
About Klotho Neurosciences Inc Com
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Klotho Neurosciences Inc Com's market cap?
Klotho Neurosciences Inc Com's market capitalization is USD 37.72M.
What does Klotho Neurosciences Inc Com do?
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.